Article | May 13, 2026
Dr. McLean brings industry‑leading biomechanics and wearable technology expertise to Secretariat, strengthening the firm’s ability to address complex, technology‑driven disputes.
May 18, 2022
Dr. Stan Panis of Intensity* provided statistical analysis on behalf of the Florida Attorney General in a lawsuit over failure to perform due diligence on prescriptions.
Intensity worked with Kellogg, Hansen, Todd, Figel, & Frederick PLLC on behalf of the Florida Attorney General in litigation alleging that a pharmacy chain failed to perform due diligence on prescriptions for opioid painkillers.
During its work, Intensity analyzed shipments of opioid and related drugs from three major distributors to pharmacies. In addition, Intensity analyzed hundreds of millions of prescriptions for opioids and opioid cocktails filled by two major pharmacy chains, including tens of millions of red-flagged prescriptions that could have prompted the pharmacies to carry out due diligence and document the results.
Intensity designed and implemented statistical samples of about 2,000 prescriptions and scaled up the results to the populations of red-flagged prescriptions. The samples were two-stage samples: in the first stage, 50 pharmacy locations were selected. In the second stage, prescriptions from those pharmacies were selected. The two-stage design reduced the burden on the defendants because many due diligence notes were reportedly kept on paper at their respective locations.
Dr. Stan Panis of Intensity submitted multiple expert reports, provided deposition testimony, and testified at trial. The settlement marks the end of a month-long trial for the final defendant in Florida’s litigation over the opioid crisis. Other defendants had settled before the trial commenced.
ABC News coverage of the settlement can be found here. Law360 coverage (subscription may be required) can be found here. In addition, Bloomberg Law coverage can be found here.
*Work performed by individuals while employed by Intensity, LLC. Intensity was acquired by Secretariat in February 2023.
Dr. McLean brings industry‑leading biomechanics and wearable technology expertise to Secretariat, strengthening the firm’s ability to address complex, technology‑driven disputes.
A recent study by Tatyana Avilova, Economist at Secretariat has been selected by the Editor of JAMA Health Forum as an Editor’s Choice: Clinical Trial of 2025.
Secretariat Experts Recognized in Lexology’s 2026 Investigations Report
Ten of Secretariat experts have been recognized in the Lexology Index 2026 Investigations report, produced in partnership with Global Investigations Review. The guide highlights leading investigations lawyers, digital forensic specialists, and forensic accountants who are trusted to support the most demanding matters worldwide.